A three-arm randomized trial for Achilles tendinopathy: eccentric training, eccentric training plus a dietary supplement containing mucopolysaccharides or passive stretching plus dietary supplement containing mucopolysaccharides

Conclusions MCVC seems to be safe and therapeutically useful for management of tendinopathies, providing some additional benefit to the physical therapy. This is especially evident in early stages of the disease, when the tendon doesn’t present severe matrix and vascular changes. Trial registration NCT01691716, September 2012.
Source: Current Therapeutic Research - Category: Drugs & Pharmacology Source Type: research